Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885596 · ClinicalTrials.gov registry record · Phase 2
Open-Label CA-008 (Vocacapsaicin) in Bunionectomy
A Phase 2 study, sponsored by Concentric Analgesics.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT03885596 is a Phase 2 study that has completed, run by Concentric Analgesics. The registered enrollment target is 36 participants.
The verdict
NCT03885596, a Phase 2 study, has completed, sponsored by Concentric Analgesics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
A Phase 2, open-label study of CA-008 to evaluate post-surgical pain control with CA-008.
Interventions
- DRUG Ketorolac
- DRUG Bupivacaine Hydrochloride
- DRUG Fentanyl
- DRUG CA-008
- DRUG Acetaminophen IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2019-10-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03885596
The ClinicalTrials.gov registry entry for NCT03885596 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Concentric Analgesics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ketorolac is the first listed.
NCT03885596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03885596 about?
NCT03885596 is a clinical study titled "Open-Label CA-008 (Vocacapsaicin) in Bunionectomy". A Phase 2, open-label study of CA-008 to evaluate post-surgical pain control with CA-008.
What is the current status of trial NCT03885596?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2019-03-25. Estimated completion is 2019-10-22.
What interventions are being tested in trial NCT03885596?
The interventions under investigation include: Ketorolac (DRUG), Bupivacaine Hydrochloride (DRUG), Fentanyl (DRUG), CA-008 (DRUG), Acetaminophen IV (DRUG).
Who is sponsoring clinical trial NCT03885596?
This trial is sponsored by Concentric Analgesics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.